Literature DB >> 1584909

Stereotaxic core biopsy of breast lesions.

D J Dronkers1.   

Abstract

In 70 selected patients with suspect breast lesions at mammography, accurate, high-speed stereotaxic core-cut biopsy (SCCB) was performed with a biopsy gun. In 17 of the patients, no surgery was performed. The results of SCCB were normal in 11 of these patients; in six patients, the lesion disappeared after SCCB. In 53 of the patients, SCCB was followed by surgical biopsy. In 48 cases (91%), the results of SCCB and surgical biopsy were concordant. Of the 45 carcinomas found at surgery, 41 (91%) were correctly diagnosed with SCCB. There were no false-positive results. SCCB was nondiagnostic (no representative material sampled) in three patients (6%), and in two patients (4%) a false-negative result was obtained. The infiltrating character of the tumor was correctly diagnosed with SCCB in 80% of cases. These results confirm that this radiologic procedure is an acceptable alternative to excisional biopsy.

Entities:  

Mesh:

Year:  1992        PMID: 1584909     DOI: 10.1148/radiology.183.3.1584909

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

1.  Stereotactic breast biopsy as an alternative to open excisional biopsy.

Authors:  M J Cross; W P Evans; G N Peters; J H Cheek; R C Jones; P Krakos
Journal:  Ann Surg Oncol       Date:  1995-05       Impact factor: 5.344

2.  Mammographically detected breast cancer. Benefits of stereotactic core versus wire localization biopsy.

Authors:  J H Yim; P Barton; B Weber; D Radford; J Levy; B Monsees; F Flanagan; J A Norton; G M Doherty
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

3.  Clinically occult breast carcinoma: diagnostic approaches and role of axillary node dissection.

Authors:  S Meterissian; B D Fornage; S E Singletary
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

Review 4.  When can stereotactic core biopsy replace excisional biopsy?--A clinical perspective.

Authors:  M Morrow
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

5.  Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis.

Authors:  H M Verkooijen; P H Peeters; E Buskens; V C Koot; I H Borel Rinkes; W P Mali; T J van Vroonhoven
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

6.  Changing attitudes toward needle biopsies of breast cancer in Shanghai: experience and current status over the past 8 years.

Authors:  Shuang Hao; Zhe-Bin Liu; Hong Ling; Jia-Jian Chen; Ju-Ping Shen; Wen-Tao Yang; Zhi-Min Shao
Journal:  Onco Targets Ther       Date:  2015-10-09       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.